StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Onconetix's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.31M. For fiscal 2025 it was -$9.68M. The highest annual figure on record is -$2.04M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.68M–
FY2024Dec 31, 2024-$10.50M–
FY2023Dec 31, 2023-$13.58M–
FY2022Dec 31, 2022-$8.68M–
FY2021Dec 31, 2021-$2.04M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.92M–
Q1 FY2026Mar 31, 2026-$2.12M–
Q4 FY2025Dec 31, 2025-$3.09M–
Q3 FY2025Sep 30, 2025-$3.18M–
Q2 FY2025Jun 30, 2025-$1.41M–
Q1 FY2025Mar 31, 2025-$2.00M–
Q4 FY2024Dec 31, 2024-$917.65K–
Q3 FY2024Sep 30, 2024-$1.15M–
Q2 FY2024Jun 30, 2024-$3.20M–
Q1 FY2024Mar 31, 2024-$5.23M–
Q4 FY2023Dec 31, 2023-$4.31M–
Q3 FY2023Sep 30, 2023-$3.04M–
Q4 FY2022Dec 31, 2022-$2.80M–
Q3 FY2022Sep 30, 2022-$1.81M–
Q2 FY2022Jun 30, 2022-$3.17M–
Q1 FY2022Mar 31, 2022-$886.09K–
Q4 FY2021Dec 31, 2021-$674.40K–
Q3 FY2021Sep 30, 2021-$730.48K–
Q2 FY2021Jun 30, 2021-$382.81K–
Q1 FY2021Mar 31, 2021-$256.55K–

More Onconetix figures

See a number that looks wrong?